Aesica Invests in Prefilled Syringe Production, Other Drug-Delivery Formats

Global contract development and manufacturing organization (CDMO) Aesica has acquired new manufacturing equipment capable of processing 5000 prefilled syringes per batch. Currently undergoing validation via process simulation trials, this latest addition to Aesica's Nottingham site will enable the CDMO to support clients across the EU and U.S. markets. Validation is expected to be completed by January 2014.

Aesica sees huge growth for prefilled syringes both in the United States and Europe, particularly for trials involving proteins and vaccines, as it removes the risk of dosing errors, contamination and needle injuries, the company reports.

The new equipment can also support production of products like pen and cartridge syringes as well as nasal devices. Over the next three years, Aesica is targeting production of 900,000 units and is already in advanced discussions with one company for the scale-up of a clinical trial product for which a joint validation is imminent.

“Over the last few years, Aesica has really accelerated its credibility in the aseptic market and pre-filled syringes are a natural evolution towards providing a complete product portfolio for our clients, and a reflection of the direction the wider market is heading," said Ian Lafferty, Site Director Nottingham, in a statement. "Demand is increasing for these products and very few other CDMOs are currently able to supply this in such quantities for clinical trials. Biotechnology companies are already starting to make contact with us and I would envisage a steady uptake across the US and in particular Europe where we are likely to see huge growth rates.”

Aesica currently employs approximately 1300 people. In addition to its headquarters in Newcastle upon Tyne, UK, Aesica has development and manufacturing sites across Europe including Cramlington, Nottingham and Queenborough in the UK, as well as sites in Monheim and Zwickau in Germany and Pianezza in Italy. It also has sales representation in San Diego and Shanghai.

No votes yet